Editorial: Are natural products, used as antitumoral/antiangiogenic agents, less toxic than synthetic conventional chemotherapy?

Affiliations

¹ Bioprospection and Biotechnology Laboratory, National Institute of Amazonian Research (INPA), Manaus, Brazil.
² Faculty of Pharmaceutical Sciences, Federal University of Amazonas (UFAM), Manaus, Brazil.
³ CIBA, Northwest Research and Transfer Center of the Province of Buenos Aires (UNNOBA), CIT NOBA (UNNOBA-UNSAdA-CONICET), Junin, Bs.As., Argentina.

Editorial

Cecilia Veronica Nunez et al. Front Pharmacol. 2022.

. 2022 Oct 21:13:1055516.

doi: 10.3389/fphar.2022.1055516. eCollection 2022.

¹ Bioprospection and Biotechnology Laboratory, National Institute of Amazonian Research (INPA), Manaus, Brazil.
² Faculty of Pharmaceutical Sciences, Federal University of Amazonas (UFAM), Manaus, Brazil.
³ CIBA, Northwest Research and Transfer Center of the Province of Buenos Aires (UNNOBA), CIT NOBA (UNNOBA-UNSAdA-CONICET), Junin, Bs.As., Argentina.

No abstract available

Keywords: antiangiogenic; antitumoral; mechanisms of action; natural products; new drugs.

Comment on

Editorial on the Research Topic Are natural products, used as antitumoral/antiangiogenic agents, less toxic than synthetic conventional chemotherapy?

1. Braicu C., Mehterov N., Vladimirov B., Sarafian V., Nabavi S. M., Atanasov A. G., et al. (2017). Nutrigenomics in cancer: Revisiting the effects of natural compounds. Semin. Cancer Biol. 46, 84–106. 10.1016/j.semcancer.2017.06.011 - DOI - PubMed
1. Tuorkey M. J. (2015). Cancer therapy with phytochemicals: Present and future perspectives. Biomed. Environ. Sci. 28 (11), 808–819. 10.3967/bes2015.112 - DOI - PubMed